Ian T. Bothwell is CFO & 10% at Organicell Regenerative Medicine, Inc. (BPSR). They have made 15 open-market trades across 3 companies since 2008, most recently 2026-01-14.
CIK 0001207638
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $161K since 2008, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BPSR | SELL | 2021-06-17 | 2021-06-21 | $0.14 | $7K | N/A | N/A | N/A |
| BPSR | SELL | 2021-06-14 | 2021-06-16 | $0.15 | $29K | N/A | N/A | N/A |
| BPSR | SELL | 2021-06-09 | 2021-06-11 | $0.14 | $40K | N/A | N/A | N/A |
| BPSR | SELL | 2021-06-04 | 2021-06-08 | $0.14 | $27K | N/A | N/A | N/A |
| BPSR | SELL | 2021-06-01 | 2021-06-03 | $0.17 | $24K | N/A | N/A | N/A |
| BPSR | SELL | 2021-05-26 | 2021-05-28 | $0.18 | $35K | N/A | N/A | N/A |
| BPSR | SELL | 2021-05-21 | 2021-05-25 | $0.19 | $38K | N/A | N/A | N/A |
| BPSR | SELL | 2021-05-18 | 2021-05-20 | $0.21 | $42K | N/A | N/A | N/A |
| BPSR | SELL | 2021-05-13 | 2021-05-17 | $0.23 | $41K | N/A | N/A | N/A |
| BPSR | SELL | 2021-05-10 | 2021-05-12 | $0.29 | $44K | N/A | N/A | N/A |
| BPSR | SELL | 2021-05-05 | 2021-05-07 | $0.27 | $56K | N/A | N/A | N/A |
| BPSR | SELL | 2021-05-03 | 2021-05-05 | $0.34 | $34K | N/A | N/A | N/A |
| BPSR | SELL | 2021-04-29 | 2021-04-30 | $0.45 | $45K | N/A | N/A | N/A |
| ENGY | BUY | 2014-01-15 | 2014-03-19 | $0.11 | $36K | N/A | N/A | N/A |
| RVEP | BUY | 2008-03-07 | 2008-03-11 | $14.19 | $125K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.